Treating Bunny Lines: Avoiding Over-Relaxation with Botox

Watch a patient laugh in profile and you’ll spot them immediately: diagonal creases that flare from the upper nasal bridge toward the medial cheek. Bunny lines are small, but they can steal attention from the eyes and create a pinched look when they’re overactive. Correcting them is deceptively tricky. Treat them too aggressively and the smile turns stiff, the midface looks flat, or the brow compensates in ways that throw off balance. With the right dosing, depth, angle, and context, you can soften the lines without silencing expression.

Why bunny lines don’t behave like crow’s feet

Bunny lines are primarily driven by the transverse fibers of the nasalis, with accessory input from the levator labii superioris alaeque nasi (LLSAN) and depressor septi nasi in expressive smilers and nasal flarers. Unlike the orbicularis oculi that fans widely at the lateral canthus, the nasalis sits tightly over bone and fascia with less soft tissue padding. That anatomic reality matters for toxin behavior. Small volumes travel farther than you’d expect along fascial planes on the thin nasal sidewall. Diffusion is easier to misjudge, and the impact of a single extra unit is larger. Patients also recruit the nasalis differently based on dominance patterns. Hyperactive nasal scrunchers lift or narrow the nose with emotion, anger, or concentration, which means their bunny lines deepen early and asymmetrically.

Treating bunny lines in isolation is rarely enough. Overactivity can be compensatory when the glabella and crow’s feet have been heavily relaxed. The nasalis starts doing extra work to convey expression, and the lines worsen after a seemingly successful upper-face session. This is where the art lies: softening without over-relaxing, and preserving the smile’s character.

Mapping the muscle and reading the animation

I start with three passes of dynamic assessment. First, a neutral face to map resting lines. Second, a maximal scrunch of the nose, cheeks, and eyes together to delineate nasalis bulk and the vector of the creases. Third, habitual expression, the one they use in conversation. Most patients never show their true scrunch on cue, but they reveal it during small talk. I watch for ipsilateral dominance, the influence of glasses or contacts (chronic squinters), and whether nasal flare accompanies the wrinkle.

Palpation helps. On light pinch, the nasalis belly can be felt just lateral to the nasal bone along the mid-sidewall. In thicker skin, you may locate it by tracing the line that appears when the patient smiles with a slight sniff. If the crease points more inferiorly toward the alar base, the LLSAN is recruiting. If the nasal tip dips or the philtrum shortens during a scrunch, depressor septi is in the mix. These nuances steer dose and placement.

Dose ranges that avoid the “frozen smile”

For most adult faces, conservative microdosing is safer around the nose than standard crow’s feet protocols. In practice, I start with 2 to 4 units per side for the main nasalis point, then consider a second micro-spot of 1 to 2 units if the crease has a longer tail toward the malar crescent. Very fine skin, especially in low-BMI patients, often needs only 1 to 2 units per side. High-intensity exercisers and those with thicker dermis may land in the 3 to 6 unit range per side after a test session proves tolerance.

Two patterns help reduce over-relaxation. One, split the dose between two shallow blebs rather than one deeper bolus. Two, hold back a small reserve to use at the touch-up visit. Incremental dosing respects diffusion and gives room to correct asymmetry.

Depth, angle, and diffusion control on a tight canvas

The nasal sidewall leaves no room for error. A 32 to 34 gauge needle at intradermal to very superficial subdermal depth is my default. I angle almost parallel to the skin surface, with a slight bevel up, to watch for blanching and prevent inadvertent deposition into deeper planes. A tiny wheal is acceptable if the skin is robust. In thin skin, I avoid wheals and place just superficial to the muscular fascia. The goal is to catch the upper fibers without tracking inferiorly toward the levator labii or alar rim.

I favor low-volume injections, typically 0.02 to 0.04 mL per micro-spot, to minimize spread. Botulinum toxin type A diffusion increases with higher dilution and larger volumes. For bunny lines, this is a liability. I usually reconstitute at 2 to 2.5 units per 0.1 mL for confident microdosing. If the patient has a history suggesting faster metabolism, I may keep the concentration consistent but plan for earlier reassessment rather than inflating volume. Precision beats blanket coverage here.

The dilution myth and reality on the nose

Injectors often debate dilution ratios as if one formula fits all areas. It doesn’t. On the nasal sidewall, higher concentration provides firmer control of spread, which reduces risk to adjacent elevators of the lip and alar structures. The trade-off is a slightly higher risk of a visible bleb if you inject too shallowly or too quickly. With a slow injection and the needle plane nearly parallel to the dermis, you can avoid that consequence. What I avoid is low-concentration, high-volume deposition near the alar groove. I have seen that drift weaken the LLSAN and produce a subtle gummy smile correction the patient never asked for.

Where to mark, and where not to go

Marking helps new injectors, but even for experienced hands it focuses attention. I mark a single primary point on each side along the mid-nasal sidewall, roughly at the intersection where the deepest diagonal crease forms during a natural smile. A second optional point sits up to a centimeter lateral and slightly superior if the line extends toward the malar region. I stay at least 1 cm from the medial canthus to protect the orbicularis and avoid periorbital spread. Inferiorly, I keep a buffer from the alar base to protect the LLSAN and muscles of the upper lip.

The no-go zones are as instructive as the targets. Do not chase faint infraorbital creases with toxin in the same pass. Those are often skin quality issues or the shadow of the tear trough, better addressed with skin remodeling or energy-based treatments later. Avoid tracking along the nasal bridge too close to the radix, especially in male patients with thick glabellar corrugators, because the patient may be compensating with nasalis after a heavy glabellar treatment.

How facial dominance and habit change the plan

Hyperactive expressers and those with dominant nasalis recruitment across one side of the face are the group most likely to end up over-treated if you follow a standard map. I weigh three factors: baseline muscle strength by palpation during scrunch, pattern asymmetry, and the person’s communication style. The patient who tells stories with their face often needs microdosing that respects their signature expressions.

When asymmetry is obvious, I split the plan: perhaps 3 units on one side, 1 to 2 on the other, then reassess in two weeks for incremental correction. It’s better to leave faint remnants of a crease than to flatten one side and create a lopsided smile. I also ask if they flare their nostrils when they run or lift weights. Active nasal flare can be treated, but it requires even more caution to avoid changing airflow perception and speech resonance.

Interaction with other upper-face zones

Most complaints about bunny lines appear after a change elsewhere. Treat a glabellar complex with robust dosing and the brain finds another channel for emotional signal. Nasalis steps in. This is not a failure of technique, it’s a network effect of facial expression. When planning multi-area treatment, I sequence in a way that preserves hierarchy.

I often start with conservative glabellar and crow’s feet dosing, then under-dose the nasalis at the same visit if needed. Two weeks later, I adjust bunny lines with confidence, because I can see the new baseline. If the patient already has heavy toxin in the upper face and the bunny lines are now exaggerated, I approach with even smaller aliquots than usual.

Managing diffusion risk near the orbit and lip

The safety margins near the orbital rim and perioral elevators are small. Ectropion is not a usual risk here, but weakening the medial orbicularis can produce a strange smile or uneven squint. Weakening the LLSAN or levator labii superioris can smooth a gummy smile, which sounds tempting until the patient reports that their smile looks blunted. Unless the smile line is a stated goal, I avoid this trade.

To control diffusion spread, I space injection points at least 7 to 10 mm apart, maintain shallow depth, and keep the plunger slow. If you see blanching or feel less resistance than expected, stop and reassess your plane. Minimal bruising is common, but notable edema on the thin sidewall suggests volume was too high.

Onset, longevity, and why bunny lines feel like outliers

Bunny line corrections often show effect within 3 to 5 days, which is slightly faster than some forehead results, likely because the target is small and superficial. Longevity ranges widely, from 8 to 12 weeks in expressive patients to 12 to 16 weeks in quieter faces. High-intensity exercise, high muscle mass, and fast metabolism tend to shorten duration. I have patients who burn through nasalis dosing by week 10 no matter what, but they prefer a soft, short-lived result over a flat, longer one.

Repeated conservative dosing can retrain the pattern. Over 3 to 4 sessions, many patients stop over-recruiting the nasalis for expression. They reclaim subtlety upstream, in the glabella or orbicularis, even with lighter doses there. This is the long-term benefit of microdosing: it nudges the facial feedback loop rather than shutting it down.

Preventing over-relaxation starts at the consult

I ask patients to describe what they like about their smile. Some mention a slight nose scrunch that telegraphs humor or playfulness. If they cherish that signal, we preserve it. Setting expectations matters: bunny lines can be softened, not erased, when we protect expression. I also explain that deeper etched lines are partly skin quality issues. Toxin can reduce dynamic folding, but the true imprint often needs support from collagen remodeling over time.

This is where combination therapy has a role. Fractional radiofrequency or microneedling, light peels, or targeted biostimulators in the malar transition zone can improve texture so that fewer nasalis fibers must be weakened to achieve a smooth look. Less toxin equals botox NC less risk.

Technique notes that keep results natural

I prefer seated injections. Gravity shows real-world drape, and the patient’s habitual animation is easier to read. I stabilize the tip of the nose gently with my non-dominant hand so that any micro-flare doesn’t shift my target. I keep the needle bevel up, enter almost tangentially, then deposit a tiny volume while watching for minimal tenting. If I see the skin lift more than intended, I withdraw slightly, reposition, and slow down. Wiping the area with saline after each spot reduces any surface pooling that could migrate.

For very thin skin, a 34 gauge needle improves finesse at the cost of slower delivery. The extra few seconds are worth it. I avoid topical anesthetic on the nasal sidewall, not because of safety, but because it can obscure blanching and change tissue turgor, making diffusion harder to judge.

image

Touch-ups: timing and decision-making

I book a check at 10 to 14 days. If the crease remains prominent during natural speech and there’s no sign of over-relaxation, I add 0.5 to 1 unit per side, sometimes just on the dominant side. More often than not, that tiny addition completes the result. I avoid same-day chases. The nasal sidewall continues to settle for a few days after onset, and overcorrection is almost always top botox near me a timing error, not a dose necessity.

If asymmetry appears after onset, I look upstream before adding more nasalis toxin. A slightly lifted brow tail or a heavy lateral orbicularis on one side could be driving compensatory scrunch. Tweaking a crow’s feet point by 1 to 2 units can even out the animation without further quieting the nose.

Special populations and edge cases

First-timers: I go lighter on dose and tighter on placement. Their feedback in daily life will guide the next round. It is easier to teach a new face to accept subtle change than to recover from a flat first impression.

Expressive professionals: actors, presenters, teachers. They need movement. I microdose and accept short longevity. The currency here is authenticity, not months on the calendar.

Male anatomy: thicker skin and heavier muscle fibers often require slightly more units, but the diffusion risk remains. I keep concentration high and volume low, then reassess early.

Thin skin and low subcutaneous fat: special caution. Consider 1 to 2 units per side only, with a true intradermal plane and a dry technique. Expect earlier touch-ups.

Patients seeking gummy smile correction: treat LLSAN and possibly depressor septi explicitly if indicated. Don’t piggyback that outcome onto bunny line treatment by chance. Separate goals produce cleaner consent and more predictable smiles.

When results fall short or wear off fast

If the effect is minimal at two weeks despite correct placement, consider three explanations: under-dosing relative to muscle strength, faster metabolism with higher exercise intensity, or improper plane. I adjust by adding 1 to 2 units per side and tightening the depth. If a patient consistently metabolizes toxin quickly across all areas, I tighten treatment intervals. I avoid using larger volumes or wider fields to chase longevity around the nose. It invites spread and flatness.

True resistance to botulinum toxin A is rare, but reduced responsiveness can occur with very frequent high-dose exposure or formulation switching without proper unit conversion. If I suspect lowered sensitivity, I verify that the glabella and forehead responded normally. If they did, the issue is local technique, not systemic resistance. If multiple areas seem blunted, consider spacing treatments longer, ensuring proper storage and handling, or trialing a different serotype formulation with accurate conversion, all while keeping the bunny line plan conservative.

Storage and handling details that matter more than you think

Potency preservation sounds like a backroom concern, yet it impacts small-dose areas most. I reconstitute with preservative-free saline, keep vials refrigerated, and use them within the timeframe recommended by the manufacturer and clinic protocol. A micro-spot of under-potent toxin does nothing, then the touch-up gets blamed. Around the nose there is no margin. Precision demands reliable product.

Avoiding the domino effect on facial harmony

The face is a system. Flatten the nasalis too much and the eye corner can look a touch wider, the cheek less lifted, and the emotional signal of a grin weaker. Subtlety protects proportion. I remind patients that smoothness is not the only metric. Harmony, balance between upper lip movement and cheek lifting, and congruent brow motion matter more. A small line that remains during peak laughter often reads as warmth, not age.

Troubleshooting common pitfalls

Over-flattened smile: back off on future doses, allow full washout, and consider small stimulation of malar support with non-toxin options to recapture vitality.

Residual etched line at rest: address skin texture. Consider light biostimulation, fractional energy, or a delicate intradermal collagen induction strategy rather than more toxin.

New asymmetry after correcting bunny lines: examine brow and crow’s feet balance. Adjust there before adding nasalis units.

Alar heaviness or altered nasal flare after treatment: pause toxin to that zone, document baseline flare photos for future planning, and let the effect resolve. If nasal breathing perception changes, reassure and monitor. It nearly always normalizes as the effect fades.

A stepwise microdosing approach for reliable, natural outcomes

    Map animation with three expressions: neutral, maximal scrunch, and conversational smile. Mark only where the dynamic crease peaks. Use concentrated, low-volume micro-spots: 1 to 3 units per point, 1 to 2 points per side, superficial plane with a near-parallel angle. Protect borders: keep distance from the alar base and medial canthus, and avoid chasing adjacent fine lines in the same session. Schedule a 10 to 14 day review: add 0.5 to 1 unit selectively if needed, prioritizing symmetry and expression over complete erasure. Reassess upstream contributors: adjust crow’s feet or glabella lightly before layering more toxin on the nasalis.

How bunny line treatment fits the broader plan

Bunny lines should be folded into a unified treatment map. Forehead and glabellar dosing determine how the brow moves. Crow’s feet control how the eye corners signal joy. The nasalis is the punctuation mark. If you are already planning for brow lift mechanics, periorbital safety margins, and glabellar strength testing, add the nasalis as a quiet aside, not the headliner. That mindset keeps doses small and movements honest.

As patients return over months, the plan often simplifies. Many need fewer units as their muscle memory adapts. Some will prefer a bit of the scrunch returning between sessions. I log those preferences like I would a favorite brow height or dimple. The best results look like the patient, just better rested.

Final thoughts from the chair

The temptation with small areas is to treat them as small decisions. Bunny lines prove the opposite. A few units on the nasal sidewall can change how a face smiles, how a story lands, and how the eye and cheek coordinate. Respect the anatomy, keep the canvas dry and the doses light, and leave room for a tiny touch-up. You’ll avoid the flat, over-relaxed look and preserve what drew you to the face in the first place.